Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertroph
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Jean-Luc Balligand Burkert Pieske Rolf Wachter Stefan D. Anker Gerasimos Filippatos Piotr Ponikowski Fausto Pinto |
| Publication date | October 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |